AMPA Receptor

AMPA receptor antagonists and modulators act on glutamate-gated ion channels that carry fast excitatory transmission. The name comes from the selective agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). Each receptor is a tetramer of glutamate receptor subunits 1 to 4 (GluA1 to GluA4), first cloned in 1989. Alternative splicing gives flip and flop forms of each subunit, which differ in desensitization. NBQX and DNQX are competitive quinoxalinedione antagonists that also block kainate receptors. GYKI-52466 dihydrochloride is a noncompetitive antagonist of the 2,3-benzodiazepine class. Positive modulators include cyclothiazide, which reduces desensitization, aniracetam and the ampakine Ampalex.

Items 76-100 of 127

  • Cl-HIBO
    Cat. No.
    A67197

    Cl-HIBO

    Cl-HIBO is a highly selective agonist for the GluR1 and GluR2 subtypes of AMPA receptors, exhibiting EC50 values of 4.7 μM and 1.7 μM, respectively. This compound demonstrates potent activity as an AMPA receptor agonist with an IC50 of 0.22 μM. Additionally, Cl-HIBO displays desensitizing properties, making it a valuable tool for research in neuropharmacology and studies of synaptic transmission.

    1 mg
    $110.00
    25 mg
    $1,275.00
    All 4 sizes
  • PF-06462894
    Cat. No.
    A67205

    PF-06462894

    PF-06462894 is a negative allosteric modulator of metabotropic glutamate receptor 5 (mGluR5). It demonstrates efficacy in modulating mGluR5 activity in both rat and nonhuman primate models. This compound is valuable for investigating the role of mGluR5 in various neurological disorders and can be used in research focused on synaptic transmission and plasticity.

    Out of stock

    All 3 sizes
  • NPEC-caged-(S)-AMPA
    Cat. No.
    A67207

    NPEC-caged-(S)-AMPA

    NPEC-caged-(S)-AMPA is a photolabile caged analog of (S)-AMPA, specifically designed to target and activate AMPA receptors. This compound utilizes the NPEC photoprotecting group to selectively release (S)-AMPA upon illumination, enabling precise spatial and temporal control of receptor activation. It serves as a valuable tool in neuroscience research, facilitating studies on synaptic transmission and signal transduction pathways mediated by glutamate receptors.

    Out of stock

    All 3 sizes
  • AMPA receptor modulator-11
    Cat. No.
    A67208

    AMPA receptor modulator-11

    AMPA receptor modulator-11 is a positive allosteric modulator of the AMPA receptor, enhancing synaptic transmission and promoting excitatory neurotransmission. This compound plays a significant role in research related to neuropsychiatric disorders such as depression, schizophrenia, Alzheimer’s disease, and attention deficit hyperactivity disorder (ADHD). Its ability to selectively target AMPA receptors makes it an essential tool for exploring therapeutic strategies in these conditions.

    Out of stock

    All 3 sizes
  • JNJ-56022486
    Cat. No.
    A67212

    JNJ-56022486

    JNJ-56022486 is a potent negative modulator of the AMPA receptor, exhibiting a Ki value of 19 nM and selective antagonism for TARP-γ8. This compound demonstrates effective blood-brain barrier permeability, making it suitable for in vivo studies. JNJ-56022486 is primarily utilized in research focused on epilepsy and related neurological disorders, providing a valuable tool for investigating synaptic transmission and excitability in the central nervous system.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • CP-465022 hydrochloride
    Cat. No.
    A67214

    CP-465022 hydrochloride

    CP-465022 hydrochloride is a selective noncompetitive antagonist of the AMPA receptor, exhibiting significant anticonvulsant activity. It effectively inhibits kainate-induced responses in rat cortical neurons with an IC50 of 25 nM. This compound serves as a valuable tool for exploring the physiological and pathophysiological roles of AMPA receptors in various neurological contexts.

    Out of stock

    All 3 sizes
  • Irampanel
    Cat. No.
    A67233

    Irampanel

    Synonyms: BIIR 561

    Irampanel is an AMPA receptor antagonist that selectively blocks excitatory neurotransmission by inhibiting AMPA receptor activity. Additionally, it acts as a voltage-dependent sodium channel blocker, leading to a decrease in neuronal excitability. This compound has demonstrated efficacy in reducing kainate-induced currents in rat cortical neurons, making it a valuable tool for research applications related to neuropharmacology and the investigation of excitatory synaptic transmission.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • TDPAM02
    Cat. No.
    A67236

    TDPAM02

    TDPAM02 is a positive allosteric modulator targeting the AMPA receptor GluA2. It binds specifically to the ligand-binding domain (LBD) of the GluA2 flop subtype, exhibiting an IC50 value of 1.4 nM. By stabilizing the activated conformation of GluA2 receptors, TDPAM02 effectively delays receptor deactivation and desensitization. This compound is valuable for research focused on enhancing excitatory synaptic transmission in the central nervous system.

    Out of stock

    All 3 sizes
  • ZK 187638
    Cat. No.
    A67240

    ZK 187638

    ZK 187638 is an AMPA receptor antagonist that effectively inhibits kainate-induced currents in cultured hippocampal neurons, demonstrating noncompetitive antagonism with an IC50 of 3.4 μM. This compound is valuable for research applications focused on synaptic transmission, neuroprotection, and the study of excitotoxicity in neurodegenerative disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • YM928
    Cat. No.
    A67245

    YM928

    YM928 is a noncompetitive antagonist of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. This compound effectively inhibits AMPA receptor-mediated neurotoxicity in primary rat hippocampal cultures with an IC50 of 2 μM. Additionally, YM928 blocks AMPA-induced intracellular calcium influx (IC50 of 3 μM) and antagonizes AMPA-induced inward currents (IC50 of 1 μM). It holds potential for research into various neurological disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • AMPA receptor antagonist-3
    Cat. No.
    A67254

    AMPA receptor antagonist-3

    AMPA receptor antagonist-3 is a selective antagonist of the AMPA receptor, which plays a critical role in excitatory neurotransmission in the central nervous system. This compound is valuable for studying neurological disorders that involve dysregulation of glutamate signaling, such as epilepsy, Alzheimer's disease, and neurodegenerative conditions. Its utility in research enables the exploration of therapeutic strategies targeting excitatory neurotransmission.

    1 mg
    $155.00
    5 mg
    $365.00
    All 6 sizes
  • LY 215490
    Cat. No.
    A67262

    LY 215490

    LY 215490 is a selective, competitive antagonist of the AMPA receptor, exhibiting inhibitory potency with IC50 values of 4.8 μM against AMPA, 26.4 μM against CGS 19755, and 247 μM against kainate. This compound demonstrates neuroprotective effects, particularly in the context of focal ischaemia. LY 215490 serves as a valuable tool in studying excitatory neurotransmission and its implications in neurodegenerative diseases.

    Out of stock

    All 3 sizes
  • CP-465022 maleate
    Cat. No.
    A67264

    CP-465022 maleate

    CP-465022 maleate is a potent, selective noncompetitive antagonist of the AMPA receptor, exhibiting anticonvulsant properties. It effectively inhibits kainate-induced responses in rat cortical neurons with an IC50 of 25 nM. This compound serves as a valuable research tool to explore the role of AMPA receptors in both physiological and pathophysiological contexts.

    1 mg
    $90.00
    5 mg
    $275.00
    All 3 sizes
  • LY382884
    Cat. No.
    A67265

    LY382884

    LY382884 is a selective antagonist for the GluR5 kainate receptor. By inhibiting GluR5 activity, LY382884 effectively prevents the induction of NMDA receptor-independent long-term potentiation (LTP). This compound is valuable for research into synaptic plasticity and the underlying mechanisms of neuropharmacology.

    1 mg
    $600.00
    5 mg
    $1,285.00
    All 6 sizes
  • Irampanel hydrochloride
    Cat. No.
    A67267

    Irampanel hydrochloride

    Synonyms: BIIR-561-CL

    Irampanel hydrochloride is a potent antagonist of the AMPA receptor, acting primarily on excitatory glutamate signaling pathways. This compound effectively blocks voltage-dependent sodium channels and inhibits kainic acid-induced currents in rat cortical neurons. It is primarily used in research applications focused on neuroprotection, synaptic plasticity, and the study of neurodegenerative diseases.

    Out of stock

    All 3 sizes
  • AMPA receptor modulator-5
    Cat. No.
    A67272

    AMPA receptor modulator-5

    AMPA Receptor Modulator-5 functions as a modulator of AMPA receptors, which are critical for fast excitatory synaptic transmission in the central nervous system. This compound has demonstrated potential in the research of neurological diseases by influencing synaptic plasticity and neurotransmission. Its application extends to studies focused on cognitive functions and neurodegenerative disorders, making it a valuable tool for exploring therapeutic strategies in neuroscience.

    5 mg
    $1,125.00
    50 mg
    $2,280.00
    All 3 sizes
  • gamma-DGG acetate
    Cat. No.
    A67279

    gamma-DGG acetate

    Synonyms: γDGG acetate; γ-D-Glutamylglycine acetate

    Gamma-DGG acetate is a competitive antagonist of the AMPA receptor, exerting its effects by inhibiting excitatory glutamatergic neurotransmission. By blocking AMPA receptors, this compound modulates excitatory post-synaptic potentials (e.p.s.p.s) and is valuable in research focused on neurological processes, synaptic plasticity, and related disorders. Its reversible action makes it an essential tool for studying receptor dynamics and synaptic function in various experimental settings.

    1 mg
    $30.00
    5 mg
    $35.00
    All 5 sizes
  • EGIS-8332
    Cat. No.
    A67296

    EGIS-8332

    EGIS-8332 is a non-competitive antagonist of the AMPA receptor, effectively inhibiting AMPA-mediated currents in rat cerebellar Purkinje cells. It demonstrates a potent capability to block AMPA- and Quisqualate-induced excitotoxicity in primary cultures of telencephalon neurons, with an IC50 ranging from 5.1 to 9.0 μM. EGIS-8332 exhibits notable anticonvulsant and neuroprotective properties, making it a valuable tool for research in neurological diseases.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • YM 900
    Cat. No.
    A67298

    YM 900

    YM 900 is an AMPA receptor antagonist that selectively inhibits excitatory neurotransmission mediated by AMPA receptors. Its primary mechanism involves blocking the receptor's ion channel, thereby reducing the influx of sodium ions. This compound is valuable in research applications focused on neuroprotection, synaptic plasticity, and the study of neurological disorders related to glutamatergic signaling. Researchers may utilize YM 900 to investigate the role of AMPA receptors in various models of brain function and pathology.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • AMPA receptor antagonist-2
    Cat. No.
    A67315

    AMPA receptor antagonist-2

    AMPA Receptor Antagonist-2 is a potent antagonist of the AMPA receptor, a subtype of glutamate receptor involved in synaptic transmission. By inhibiting AMPA receptor activity, this compound plays a crucial role in research related to excitatory neurotransmission, neuroprotection, and various neurodegenerative diseases. Its application extends to studying synaptic plasticity and the mechanisms underlying conditions such as epilepsy and chronic pain.

    1 mg
    $40.00
    5 mg
    $95.00
    All 5 sizes
  • Ro 48-8587
    Cat. No.
    A67317

    Ro 48-8587

    Ro 48-8587 is a selective antagonist of the AMPA receptor, exhibiting an IC50 of 8 nM. This compound functionally inhibits AMPA receptor activity and effectively blocks AMPA-induced depolarization in rat cortical wedges. Ro 48-8587 is utilized in research related to ischemia and seizure disorders.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • BPAM363
    Cat. No.
    A67318

    BPAM363

    BPAM363 is an orally active, selective positive allosteric modulator (PAM) of AMPA receptors (AMPARs). It effectively enhances AMPAR activity in both human and rat models, exhibiting an EC2x value of 0.96 μM in rat embryonic cortical primary neurons. Additionally, BPAM363 promotes the upregulation of brain-derived neurotrophic factor (BDNF) protein expression in rat primary cortical neuronal cultures and increases AMPA-mediated excitatory postsynaptic responses in rat and mouse models. This compound is valuable for researching cognitive disorders and related neurological conditions.

    Out of stock

    All 3 sizes
  • UBP-282
    Cat. No.
    A67330

    UBP-282

    UBP-282 is a potent and selective competitive antagonist of AMPA and kainate receptors. It effectively inhibits the fast component of the dorsal root-evoked ventral root potential (fDR-VRP) with an IC50 value of 10.3 μM. In addition, UBP-282 antagonizes kainate-induced depolarizations of dorsal roots, exhibiting a pA2 value of 4.96. This compound serves as a valuable tool for investigating excitatory neurotransmission and related neurological pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • KRP-199
    Cat. No.
    A67333

    KRP-199

    KRP-199 is a potent antagonist of the α-amino-3-hydroxy-5-methylisoxazolepropionic acid receptor (AMPA-R), exhibiting a Ki of 16 nM. This compound demonstrates high selectivity for AMPA-R, contributing to significant neuroprotective effects in vivo. KRP-199 is useful for investigating mechanisms underlying neurodegenerative diseases and evaluating potential therapeutic approaches.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • TDPAM01
    Cat. No.
    A67335

    TDPAM01

    TDPAM01 is a positive allosteric modulator targeting the AMPA receptor GluA2. It specifically binds to the ligand-binding domain of the GluA2 flop subtype with an IC50 of 13.4 nM, effectively stabilizing its activated conformation. This modulation delays receptor deactivation and desensitization, facilitating sustained excitatory synaptic transmission in the central nervous system, making it valuable for research on synaptic plasticity and neuronal signaling.

    Out of stock

    All 3 sizes

Items 76-100 of 127

Added to your cart

View Cart Checkout

    Loading...